This
innovative R&D project is focused on the new technological
dimension for
the antibacterial and osseointegrated coatings. The CarLa project is
connected
with the topic of materials science and engineering (design of new
interfaces,
surfaces and coatings in form of Ag/Si doped DLC) including usage of
nanotechnologies and production processes for coatings fabrication.
Apart from
the technological part, project consists also of coatings’
characterization and
mechanical properties estimation. Project predicts also the industrial
partners
(SMEs) and commercialization of the results that is why it also
includes the
third part of research – biological tests. That consists of its
multidisciplinary character. The aim of the project is to solve the
global
problem of society and medicine on the whole world. Through that
project
inscribes to the strategic aim of the M-ERA.NET Programme –
increases
interdisciplinary cooperation in order to create a powerful network to
tackle
European and global challenges – in this case post-implantation
complications
which are caused by the infections and/or allergy induced by alloying
elements.
The expected results of this project will cover elaboration of Ag/Si
doped
carbon coatings, their mechanical verification, biological evaluation
and
testing under industrial conditions in order to introduce to the market
the new
safe product with satisfying osseointegration, antimicrobial and
mechanical
properties.The results of the CarLa Project are expected to be for the
big
benefit of the European industry and society. The industry will get an
ecological, simply, cheap and easy to implement technology in favor of
healthier society – the offer of biomaterials with better
properties giving
faster healing processes for patients and lower risk of infection
during and
after implantation. Trough that it fulfills the efforts of new
innovation
oriented economy in EU.
Thanks
to the technologies, which will be worked out in the frame of this
project, new
markets will be opened not only for these represented by the industry
partners
(dentistry and orthopedic) within the confines of the project
consortium. We
also expect that technologies we are going to apply will have a wide
range of
potential to be used in many branches of industry, also apart from
these
provided by the SME partners. The cooperation in the frame of
transnational
consortium give us a chance to exploit international technology and
market
expertise.